MS Experts Consensus Summit
December 12-14, 2013

“No Evidence of Disease Activity” as a Treatment Target in MS
Thursday, ...
MS Experts Consensus Summit
December 12-14, 2013

“No Evidence of Disease Activity” as a Treatment Target in MS
Session 3:...
MS Experts Consensus Summit
December 12-14, 2013

“No Evidence of Disease Activity” as a Treatment Target in MS
Saturday D...
MS Experts Consensus Summit
December 12-14, 2013

“No Evidence of Disease Activity” as a Treatment Target in MS
Breakout d...
Upcoming SlideShare
Loading in …5
×

No Evidence of Disease Activity as a Treatment Target in MS: Agenda Dec 2013

2,756 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,756
On SlideShare
0
From Embeds
0
Number of Embeds
1,652
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

No Evidence of Disease Activity as a Treatment Target in MS: Agenda Dec 2013

  1. 1. MS Experts Consensus Summit December 12-14, 2013 “No Evidence of Disease Activity” as a Treatment Target in MS Thursday, December 12, 2013 Afternoon and evening arrivals 6:30 – 9:00PM Buffet dinner available at Wynn Las Vegas (Lafleur 2 Room) Friday, December 13, 2013 7:00 – 8:00AM Breakfast Buffet / Registration (Petrus 1 Room) Session 1: No Evidence of Disease Activity: General Considerations (Petrus 2 Room) 8:00 – 8:20AM Welcome and Introduction – Treating to Target in MS Speaker: Richard Rudick, MD 8:20 - 8:45AM Chronic rheumatic diseases – from treatment to remission to prevention – our experience Speaker: Michael Weisman, MD 8:45 – 9:10AM What is the evidence that treatment of RRMS reduces end organ damage? Lessons from studies of brain atrophy. Speaker: Elizabeth Fisher, PhD 9:10 – 9:30AM The link between early disease activity and long-term outcome Speaker: Xavier Montalban, MD, PhD 9:30 – 9:50AM Targeting NEDA in the MS clinic: Core principals and controversies Speaker: Robert Bermel, MD 9:50 – 10:05AM Refreshment Break 10:05 –10:45AM Panel Discussion: Significance of applying NEDA to MS practice: Opportunities and challenges Panel Chair: Patricia Coyle, MD Panelists: Aaron Miller MD, Revere Kinkel MD, Andrew Goodman MD, Anne Cross MD, Alexandra Goodyear MD, MS, Andrew Solomon MD Session 2: Discussing Treatment Goals on an Individual Patient Level 10:45 – 11:00AM Discussing individualized treatment goals: The physician’s perspective Speaker: Gavin Giovannoni, MBBCh, PhD 11:00 – 11:10AM Discussing individualized treatment goals: The nurse’s perspective Speaker: Claire Hara-Cleaver, MSN, CNP 11:10 – 11:20AM Discussing individualized treatment goals: The patient’s perspective Speaker: Marjorie Heines, BS 11:20 – 12:00PM Panel Discussion: Discussing goals of therapy with patients Panel Chair: Steven Galetta, MD Panelists: Robert Fox MD, Omar Khan MD, Laura Balcer MD, MSCE, Bruce Cohen MD, John Corboy MD, Le Hua MD, Aaron Boster MD 12:00 – 1:00PM Lunch Buffet
  2. 2. MS Experts Consensus Summit December 12-14, 2013 “No Evidence of Disease Activity” as a Treatment Target in MS Session 3: Bringing Core Measures of Disease Activity to the Clinic 1:00 – 1:30PM Measuring disease status in 2013: Core measures to judge response to disease modifying therapy Speaker: Ted Phillips, MD, PhD 1:30 – 1:50PM Relapses: How to assess and capture relapses in the clinical practice setting Speaker: Ellen Mowry MD, MCR 1:50 – 2:10PM MRI lesions: Options for measuring and documenting disease activity in practice Speaker: Rob Naismith, MD 2:10 – 2:30PM Physical disability: Practical core measures for clinical use Speaker: Fred Lublin, MD 2:30 – 2:50PM Refreshment Break 2:50 – 4:00PM Panel Discussion: What can we recommend for collecting core disease activity measures in 2013 Panel Chair: Bruce Cree, MD, PhD, MCR Panelists: Tom Scott MD, Michael Racke MD, Nancy Sicotte MD, Mary Rensel MD, Clyde Markowitz MD, Sibyl Wray MD 4:00 – 5:30PM Personal time 5:30 – 6:00PM Bus to Keynote Event and Reception Bus will depart at 5:30 pm from the Wynn Ballroom and Tour Bus Entrance The Tour Bus Entrance is located near Registration Desk #3 and the Wedding Salons. 6:00 – 7:00PM Reception – Cleveland Clinic Lou Ruvo Center for Brain Health 7:00 – 7:45PM Keynote: The Lou Ruvo Center for Brain Health: A building and a mission Speaker: Larry Ruvo, Founder and Chairman, Keep Memory Alive 7:45 – 10:00PM Dinner Buffet 9:00 – 10:30PM Shuttles back to Wynn
  3. 3. MS Experts Consensus Summit December 12-14, 2013 “No Evidence of Disease Activity” as a Treatment Target in MS Saturday December 14, 2013 – Future Directions 7:00 – 8:00AM Breakfast Buffet (Petrus Room) 8:00 – 8:10AM Summary of Day 1 and Introduction of Day 2 agenda Speaker: Robert Bermel, MD 8:10 – 8:20AM How can patient advocacy groups advance the “Treat to Target” concept? Speakers: Nancy Law, BA, National MS Society Hollie Schmidt, MS, Accelerated Cure Project Session 4: Where do we go from here? 8:20 – 8:40AM Obtaining core measures of disease activity in the future: Novel methods Speaker: Jeffrey Cohen, MD 8:40 – 8:50AM Complexities and unresolved uncertainties in pursuing NEDA Speaker: Raju Kapoor, BMBCh, MA, DM, FRCP 8:50 – 10:30AM Parallel Breakout Sessions All three small groups to address the following questions: 1. Why target NEDA? What is the best evidence that it is of benefit? 2. In whom should we target NEDA? 3. How would you do it right now, when you get back to your practice? a. How would you implement the core measures? b. How would you discuss it with your patients? 4. Is there a research agenda that would advance and expand the use of NEDA as a treatment target in MS? 10:30 – 10:45AM Refreshment Break 10:45 – 12:00PM Presentation of breakout group results – Areas of consensus and next steps Led by select breakout group members Panelists: Carlo Tornatore MD, Ari Green MD, MCR, Alex Rae-Grant MD, Jack Simon MD, PhD, Tim Vollmer MD, Tanuja Chitnis MD, Myla Goldman MD, MSc 12:00PM Departures and Box Lunch
  4. 4. MS Experts Consensus Summit December 12-14, 2013 “No Evidence of Disease Activity” as a Treatment Target in MS Breakout discussion group participants: Group 1: PETRUS 2 ROOM Group 2: PALMER 1 ROOM Group 3: PALMER 2 ROOM First Robert Aaron Bruce *Suhayl *Jeffrey Elizabeth Gavin Myla Andrew Marjorie Omar Tom Andrew Timothy Laura Last Bermel Boster Cohen Dhib-Jalbut* Dunn* Fisher Giovannoni Goldman Goodman Heines Khan Scott Solomon Vollmer Balcer Tanuja John Ari Revere Clyde Aaron Michael Alex Mary *Claire Richard Jack Carlo *Brian Michael Sibyl Chitnis Corboy Green Kinkel Markowitz Miller Racke Rae Grant Rensel Riley* Rudick Simon Tornatore Weinshenker* Weisman Wray Jeffrey Patricia Bruce Anne Robert Steven Alexandra Claire Le Raju Fred Ellen Rob Ted Nancy *Emmanuelle *Timothy Cohen Coyle Cree Cross Fox Galetta Goodyear Hara-Cleaver Hua Kapoor Lublin Mowry Naismith Phillips Sicotte Waubant* West* Room Leader with Topic assigned: 1,2 3,4 1,2 3,4 1,2 3,4

×